Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimizing treatment with topical tazarotene.

Lyn C Guenther1

  • 1Division of Dermatology, University of Western Ontario, London, Ontario, Canada.

American Journal of Clinical Dermatology
|March 12, 2003
PubMed
Summary

Tazarotene effectively treats psoriasis and acne by normalizing skin cell growth and reducing inflammation. It shows superior efficacy compared to other treatments, especially in combination therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Journal of cutaneous medicine and surgery·2023
Same author

Leveraging Blockchain Technology for Informed Consent Process and Patient Engagement in a Clinical Trial Pilot.

Blockchain in healthcare today·2023
Same author

Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis.

Dermatology and therapy·2022
Same author

Skin care and hygiene among healthcare professionals during and after the SARS-CoV-2 pandemic.

SAGE open medicine·2021
Same author

Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study.

The Journal of dermatological treatment·2021
Same author

Comparison of topical antiaging creams in the management of lateral canthal lines.

Journal of cosmetic dermatology·2019

Area of Science:

  • Dermatology
  • Retinoid Therapeutics
  • Cutaneous Inflammation

Background:

  • Tazarotene is a third-generation receptor-selective retinoid.
  • It exhibits efficacy in treating psoriasis, acne vulgaris, and photoaging.
  • Mechanism of action includes normalizing keratinocyte differentiation and reducing hyperproliferation, alongside anti-inflammatory effects.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of tazarotene in dermatological conditions.
  • To compare tazarotene's comedolytic activity with other topical agents.
  • To assess the benefits of tazarotene in monotherapy versus combination therapy.

Main Methods:

  • Clinical studies comparing tazarotene 0.1% gel with tretinoin and adapalene gels.
  • Evaluation of tazarotene in combination with topical antibacterials for acne.
  • Assessment of tazarotene combined with topical corticosteroids or phototherapy for psoriasis.

Main Results:

  • Tazarotene 0.1% gel demonstrated greater comedolytic activity than tretinoin and adapalene.
  • Combination therapy with tazarotene (e.g., with mometasone furoate for psoriasis) showed enhanced efficacy compared to monotherapy or other agents.
  • Tazarotene combined with phototherapy (UVB, PUVA) yielded superior results compared to phototherapy alone.

Conclusions:

  • Tazarotene is a highly effective topical retinoid for psoriasis and acne vulgaris.
  • Combination therapy significantly enhances tazarotene's efficacy and tolerability.
  • Tazarotene offers a valuable treatment option, though contraindications (pregnancy) and potential side effects (irritation) must be considered.

Related Experiment Videos